1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Utah Medical Products, Inc.

Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients.
Kevin Cornwell

7043 S Cottonwood St
Midvale, Utah 84047-1048
Phone: 18015661200


UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024
Apr 26, 2024 02:53am

Utah Medical Products (NASDAQ: UTMD ) just reported results for the first quarter of 2024. Utah Medical Products reported earnings per share of $1.09. The company reported revenue of $11.34 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now. The post UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024 appeared first on InvestorPlace .

Utah Medical Products EPS of $1.10, revenue of $11.3M
Apr 25, 2024 19:45pm

No summary available.

Source:Seeking Alpha
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
Apr 25, 2024 13:00pm

SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024.Summary … Jetzt den vollständigen Artikel lesen